Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 30 n° 318

Riverain Technologies Issued a U.S. Patent for Vessel Suppression Technology

Posted by fidest press agency su domenica, 17 giugno 2018

Riverain Technologies, an industry leader and innovator in proprietary image analysis and machine learning technologies, announced today that the United States Patent and Trademark Office (USPTO) has awarded the company a broad patent for its technology that forms a vessel suppressed, chest CT series using deep learning and synthetic data modeling. The patent holds enormous promise for improving the detection and diagnosis of lung cancer at an earlier stage while making clinicians more efficient, a first for computer aided detection.Riverain has been issued U.S. Patent 9,990,743 for its methodology to selectively remove anatomical structures from CT scans to optimize reading accuracy and efficiency for lung cancer detection. The technology is used in the company’s premier software, ClearRead CT™. ClearRead CT is proven to lead to more accurate and efficient detection of lung nodules, the early indicator of lung cancer. A range of possible applications exists within other imaging modalities including MRI, positron emission tomography (PET), full field digital mammography and tomosynthesis, where normal structures interfere with the detection and diagnosis of disease.

Rispondi

Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo WordPress.com

Stai commentando usando il tuo account WordPress.com. Chiudi sessione /  Modifica )

Google+ photo

Stai commentando usando il tuo account Google+. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

 
%d blogger hanno fatto clic su Mi Piace per questo: